Examples include findings that metabolic profiling can discriminate and identify patients at risk of HF-related decompensation, and metabolomic profiles showing differentially expressed signaling pathways are associated with lower cyclic guanosine monophosphate/brain natriuretic peptide (cGMP/BNP) ratios in HF patients [77,78]. Here, NPPB is linked to hydrops fetalis.